SLEEP MODULATION AND NEUROPROTECTION THROUGH THE PRISM OF HERBAL PLANTS
DOI:
https://doi.org/10.15547/tjs.2025.03.009Keywords:
medicinal plants, brain health, sleep architecture, GABA, glymphatic systemAbstract
Sleep disorders, such as insomnia, excessive sleepiness, alterations in NREM/REM cycles and breathing problems during sleep affect a large proportion of the population worldwide and contribute to cognitive and emotional disorders. Due to the adverse effects and risk of addiction of synthetic hypnotics, medicinal plants (valerian, passionflower, lemon balm, lavender, etc.) are established as a safe and effective alternative. Studies show that herbal extracts modulate sleep architecture and support neurological function through various pathways of interaction. Among their effects are also facilitated falling asleep and maintaining normal sleep structure, providing neuroprotection by redox regulation, anti-inflammatory and anti-amyloidogenic properties, improvement of cerebral perfusion and stimulation the drainage of waste metabolites, the accumulation of which is associated with the development of neurodegenerative diseases. This review focuses on: the endogenous processes by which herbs modulate sleep; their neuroprotective properties; their role in metabolic clearance and the synergistic effect of combined herbal formulas.
References
Georgiev, I. Neurophysiological control of sleep with special emphasis on melatonin. Thrace Journal of Sciences, 18, 355-376. 2020.
Sa, F.; Guo, B. J.; Li, S.; Zhang, Z. J.; Chan, H. M.; Zheng, Y.; Lee, S. M. Pharmacokinetic Study and Optimal Formulation of New Anti-Parkinson Natural Compound Schisantherin A. Parkinson’s Disease, 1. https://doi.org/10.1155/2015/951361. 2015.
Liu, Y.; Wang, S.; Kan, J.; Zhang, J.; Zhou, L.; Huang, Y.; Zhang, Y. Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling. Current Neuropharmacology, 18(4), 260. https://doi.org/10.2174/1570159x17666191101125530. 2019.
Bruni, O.; Ferini‐Strambi, L.; Giacomoni, E.; Pellegrino, P. Herbal Remedies and Their Possible Effect on the GABAergic System and Sleep. Nutrients, 13(2), 530. https://doi.org/10.3390/nu13020530. 2021.
Johnston, G. A. R. GABAA Receptor Channel Pharmacology. Current Pharmaceutical Design, 11(15), 1867. https://doi.org/10.2174/1381612054021024. 2005.
Hu, Z.; Oh, S.; Ha, T.-W.; Hong, J. T.; Oh, K.-W. Sleep-Aids Derived from Natural Products. Biomolecules & Therapeutics, 26(4), 343. https://doi.org/10.4062/biomolther.2018.099. 2018.
Nahar, L.; Charoensup, R.; Kalieva, K.; Habibi, E.; Guo, M.; Wang, D.; Kvasnica, M.; Önder, A.; Sarker, S. D. Natural products in neurodegenerative diseases: recent advances and future outlook. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1529194. 2025.
Roy, K.K.; Mehta, D.K.; Das, R. Reevaluating Alzheimer's disease treatment: Can phytochemicals bridge the therapeutic gap? Neuroscience, 575, 1-18. 2025.
Wang, M.; Wang, C.; Kaiwei, Z.; Ma, S.; Jiajia, S.; Xu, S. Bioactive compounds from Chinese herbal plants for neurological health: mechanisms, pathways, and functional food applications. Frontiers in Nutrition, 12.. https://doi.org/10.3389/fnut.2025.1537363. 2025.
Zeng, J.; Wang, Z.; Zhang, X.; Zhao, A.; Qi, H.; Jiang, Y.; Cai, D.; Zeng, N. Exploring the neuroplasticity hypothesis in depression: The role of traditional Chinese herbal medicine. Phytomedicine: international journal of phytotherapy and phytopharmacology, 143, 156927. 2025.
Kennedy, D. O.; Scholey, A. The Psychopharmacology of European Herbs with Cognition-Enhancing Properties. Current Pharmaceutical Design, 12(35), 4613. https://doi.org/10.2174/138161206779010387. 2006.
Thorpy, M.J. Classification of Sleep Disorders. Neurotherapeutics, 9, 687-701. 2012.
Chen, C.; Liu, X.; Chiou, J.; Hang, L.; Li, T.; Tsai, F.; Ko, C.; Lin, T.; Liao, C.; Huang, S.; Liang, W.; Lin, Y. Effects of Chinese herbal medicines on dementia risk in patients with sleep disorders in Taiwan. Journal of ethnopharmacology, 113267. 2020.
Bent, S.; Padula, A.; Moore, D.H.; Patterson, M.; Mehling, W. Valerian for Sleep: A Systematic Review and Meta-Analysis. The American Journal of Medicine, 119(12), 1005. https://doi.org/10.1016/j.amjmed.2006.02.026. 2006.
Akiyoshi, R.; Wake, H.; Kato, D.; Horiuchi, H.; Ono, R.; Ikegami, A.; Haruwaka, K.; Omori, T.; Tachibana, Y.; Moorhouse, A.J. Microglia Enhance Synapse Activity to Promote Local Network Synchronization. eNeuro, 5, 5. 2018.
Cho, S.; Shimizu, M. Natural Sleep Aids and Polyphenols as Treatments for Insomnia. 2015.
Ohayon M.M.; Reynolds C.F. 3rd. Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD). Sleep Med. 10(9):952–60. pmid: 19748312. 2009.
Perlis M.L.; Posner D.; Riemann D.; Bastien C.H.; Teel J.; Thase M. Insomnia. Lancet. 400(10357):1047–60. pmid:36115372. 2022.
Guan, D.; Hou, Z.; Fan, B.; Bai, Y.; Wu, H.; Yu, J.; Xie, H.; Duan, Z.; Wang, F.; Wang, Q. The Extract of Piper nigrum Improves the Cognitive Impairment and Mood in Sleep-Deprived Mice Through the JAK1/STAT3 Signaling Pathway. International Journal of Molecular Sciences, 26. 2025.
Feizi, F.; Namazi, N.; Rahimi, R.; Ayati, M.H. Medicinal Plants for Management of Insomnia: A Systematic Review of Animal and Human Studies. Galen Medical Journal, 8. https://doi.org/10.31661/gmj.v8i0.1085. 2019.
Acero, N.; Ortega, T.; Villagrasa, V.; Leon, G.; Muñoz-Mingarro, D.; Castillo, E.; González-Rosende, M.E.; Borràs, S.; Ríos, J.L.; Bosch-Morell, F.; Martínez-Solís, I. Phytotherapeutic alternatives for neurodegenerative dementias: Scientific review, discussion and therapeutic proposal. Phytotherapy Research, 37, 1176-1211. 2023.
Zhang X.Y.; Guo C.Q.; Wu L.Z.; Chang Y.H.; Zhou J.L.; Wang S.M. Clinical observation of Sini San in the treatment of adolescent depression with liver qi stagnation type. Guangming J. Chin. Med., 38 (24) pp. 4783-4786. 2023.
Grabowski, W.; Karoń, K.; Karoń, Ł.M.; Zygmunt, A.E.; Drapała, G.; Pedrycz, E.; Pedrycz, D. Unlocking Better Sleep and Stress Relief: The Power of Ashwagandha (Withania somnifera) Supplementation – A Literature Review. Quality in Sport. 2024.
Kim, G.; Kim, Y.; Yoon, S.; Kim, S.; Yi, S.S. Sleep‐inducing effect of Passiflora incarnata L. extract by single and repeated oral administration in rodent animals. Food Science & Nutrition, 8, 557-566. 2019.
Donath, F.; Quispe, S.; Diefenbach, K.; Maurer, A.; Fietze, I.; Roots, I. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry, 33 2, 47-53. 2000.
Lee, E.; Chung, W. Glial Control of Synapse Number in Healthy and Diseased Brain. Frontiers in Cellular Neuroscience, 13. https://doi.org/10.3389/fncel.2019.00042. 2019.
Cheah, K.L.; Norhayati, M.N.; Husniati Yaacob, L.; Abdul Rahman, R. Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. PLoS One, 16. 2021.
Shi, L.; Chen, S.; Ma, M.; Bao, Y.; Han, Y.; Wang, Y.; Shi, J.; Vitiello, M.; Lu, L. Sleep disturbances increase the risk of dementia: A systematic review and meta-analysis. Sleep medicine reviews, 40, 4-16. 2017.
Bubu, O.M.; Brannick, M.T.; Mortimer, J.A.; Umasabor-Bubu, O.Q.; Sebastião, Y.V.; Wen, Y.; Schwartz, S.W.; Borenstein, A.R.; Wu, Y.; Morgan, D.; Anderson, W. Sleep, Cognitive impairment, and Alzheimer's disease: A Systematic Review and Meta-Analysis. SLEEP, 40. 2017.
Sung, P.; Yeh, C.; Wang, L.; Hung, P.; Muo, C.; Sung, F.; Chen, C.; Tsai, K. Increased Risk of Dementia in Patients with Non-Apnea Sleep Disorder. Current Alzheimer research, 14 3, 309-316. 2016.
de Almondes, K.M.; Costa, M.V.; Malloy-Diniz, L.F.; Diniz, B. Insomnia and risk of dementia in older adults: Systematic review and meta-analysis. Journal of psychiatric research, 77, 109-15. 2016.
Meng, M.; Shen, X.; Xie, Y.; Lan, R.; Zhu, S. Insomnia and risk of all-cause dementia: A systematic review and meta-analysis. PLoS One, 20. 2025.
Xu, W.; Tan, C.; Zou, J.; Cao, X.; Tan, L. Sleep problems and risk of all-cause cognitive decline or dementia: an updated systematic review and meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry, 91, 236-244. 2019.
Kumar, G.; Khanum, F. Neuroprotective potential of phytochemicals. Pharmacognosy Reviews, 6, 81 - 90. 2012.
Hristova, P.; Georgiev, I.P. NEUROPHYSIOLOGICAL BASIS OF DREAMING – A REVIEW. THRACIAN JOURNAL OF SCIENCES. 2024.
Kroeger, D.; Absi, G.; Gagliardi, C.; Bandaru, S.S.; Madara, J.C.; Ferrari, L.; Arrigoni, E.; Münzberg, H.; Scammell, T.E.; Saper, C.B.; Vetrivelan, R. Galanin neurons in the ventrolateral preoptic area promote sleep and heat loss in mice. Nature Communications, 9. 2018.
Gallopin, T.; Fort, P.E.; Eggermann, E.; Cauli, B.; Luppi, P.; Rossier, J.; Audinat, E.; Mühlethaler, M.; Serafin, M. Identification of sleep-promoting neurons in vitro. Nature, 404, 992-995. 2000
Sherin, J.E.; Shiromani, P.J.; McCarley, R.W.; Saper, C.B. Activation of Ventrolateral Preoptic Neurons During Sleep. Science, 271 , 216-219. 1996.
Wasowski, C.; Marder, M. Flavonoids as GABAA receptor ligands: the whole story? Journal of Experimental Pharmacology, 4, 9 - 24. 2012.
Murphy, K.; Kubin, Z.J.; Shepherd, J.N.; Ettinger, R.H. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats. Phytomedicine, 17, 674. https://doi.org/10.1016/j.phymed.2009.10.020. 2009.
Cavadas, C.; Araújo, I.; Cotrim, Amaral, T.; Ap, C.M.; Macedo, T.A.; Ribeiro, C. In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain. Arzneimittel-Forschung, 45 7, 753-5. 1995.
Losi, G.; Puia, G.; Garzon, G.; De Vuono, M.C.; Baraldi, M. Apigenin modulates GABAergic and glutamatergic transmission in cultured cortical neurons. European journal of pharmacology, 502 1-2, 41-6. 2004.
Singh, Y.N; Singh, N.N. Therapeutic Potential of Kava in the Treatment of Anxiety Disorders. CNS Drugs, 16, 731-743. 2002.
Fedurco, M.; Gregorová, J.; Šebrlová, K.; Kantorová, J.; Peš, O.; Baur, R.; Sigel, E.; Táborská, E. Modulatory Effects of Eschscholzia californica Alkaloids on Recombinant GABAA Receptors. Biochemistry Research International, 2015.
Chua, H.C,.; Christensen, E.T.; Hoestgaard-Jensen, K.; Hartiadi, L.Y.; Ramzan, I.; Jensen, A.A.; Absalom, N.L.; Chebib, M. Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism. PLoS ONE, 11. 2016.
Milanos, S.; Elsharif, S.A.; Janzen, D.; Buettner, A.; Villmann, C. Metabolic Products of Linalool and Modulation of GABAA Receptors. Frontiers in Chemistry, 5. 2017.
Silva M.I.; Silva M.A.; de Aquino Neto M.R.; Moura B.A.; de Sousa H.L.; de Lavor E.P. et al. Effects of isopulegol on pentylenetetrazol-induced convulsions in mice: possible involvement of GABAergic system and antioxidant activity. Fitoterapia 80, 506–513. 10.1016/j.fitote.2009.06.011. 2009.
Narusuye, K.; Kawai, F.; Matsuzaki, K.; Miyachi, E. Linalool suppresses voltage-gated currents in sensory neurons and cerebellar Purkinje cells. Journal of Neural Transmission, 112, 193-203. 2005.
Elsas S.M.; Rossi D.J.; Raber J.; White G.; Seeley C.A.; Gregory W.L.; Mohr C.; Pfankuch T.; Soumyanath A. Passiflora incarnata L. (Passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method. Phytomedicine. 17:940–949. doi: 10.1016/j.phymed.2010.03.002. 2010.
Singh, D. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease. Journal of Neuroinflammation, 19(1). https://doi.org/10.1186/s12974-022-02565-0. 2022.
Aalling, N.; Munk, A.S.F.; Lundgaard, I.; Nedergaard, M. The Glymphatic System: A Beginner's Guide. Neurochemical Research, 40(12), 2583. https://doi.org/10.1007/s11064-015-1581-6. 2015.
Gędek, A.; Koziorowski, D.; Szlufik, S. Assessment of factors influencing glymphatic activity and implications for clinical medicine. Frontiers in Neurology, 14. https://doi.org/10.3389/fneur.2023.1232304. 2023.
Adamu, A.; Li, S.; Gao, F.; Xue, G. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Frontiers in Aging Neuroscience, 16. https://doi.org/10.3389/fnagi.2024.1347987. 2024.
Kim, M.E.; Lee, J.S. Mechanisms and Emerging Regulators of Neuroinflammation: Exploring New Therapeutic Strategies for Neurological Disorders. Current Issues in Molecular Biology, 47(1), 8. https://doi.org/10.3390/cimb47010008. 2024.
Onyango, I.G.; Jauregui, G.V.; Čarná, M.; Bennett, J.P.; Stokin, G.B. Neuroinflammation in Alzheimer's Disease. Biomedicines, 9(5), 524. Multidisciplinary Digital Publishing Institute. https://doi.org/10.3390/biomedicines9050524. 2021.
Glass, C.K.; Saijo, K.; Winner, B.; Marchetto, M.C.; Gage, F.H. Mechanisms Underlying Inflammation in Neurodegeneration. Cell, 140(6), 918. https://doi.org/10.1016/j.cell.2010.02.016. 2010.
Xie L.; Kang H.; Xu Q. et al. Sleep drives metabolite clearance from the adult brain. Science. 342(6156):373-7. doi:10.1126/science.1241224. 2013.
Simard, M.; Nedergaard, M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience, 129(4), 877. https://doi.org/10.1016/j.neuroscience.2004.09.053. 2004.
Eide, P.K.; Pripp, A.H.; Berge, B.; Hrubos-Strøm, H.; Ringstad, G.; Valnes, L. Altered glymphatic enhancement of cerebrospinal fluid tracer in individuals with chronic poor sleep quality. Journal of Cerebral Blood Flow & Metabolism, 42, 1676 - 1692. 2022.
Yao, D.; Li, R.; Hao, J.; Huang, H.; Wang, X.; Ran, L.; Fang, Y.; He, Y.; Wang, W.; Liu, X.; Wang, M. Melatonin alleviates depression-like behaviors and cognitive dysfunction in mice by regulating the circadian rhythm of AQP4 polarization. Translational Psychiatry, 13. 2023.
Chen, S.; Wang, H.; Zhang, L.; Xi, Y.; Lu, Y.; Yu, K.; Zhu, Y.; Regina, I.; Yong, B.; Tong, F. Glymphatic system: a self-purification circulation in brain. Frontiers in Cellular Neuroscience, 19. https://doi.org/10.3389/fncel.2025.1528995. 2025.
Ding, Z.; Fan, X.; Zhang, Y.; Yao, M.; Wang, G.; Dong, Y.; Liu, J.; Song, W. The glymphatic system: a new perspective on brain diseases. Frontiers in Aging Neuroscience, 15. https://doi.org/10.3389/fnagi.2023.1179988. 2023.
Salve, J.; Pate, S.; Debnath, K.; Langade, D. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. Cureus, 11. 2019.
Mashayekh, A.; Pham, D.L.; Yousem, D.M.; Dizon, M.; Barker, P.B.; Lin, D.D. Effects of Ginkgo biloba on cerebral blood flow assessed by quantitative MR perfusion imaging: a pilot study. Neuroradiology, 53, 185-191. 2011.
Wang, B.; Cui, Z.; Zhong, Z.; Sun, Y.; Sun, Q.; Yang, G.; Bian, L. Curcumin attenuates brain edema in mice with intracerebral hemorrhage through inhibition of AQP4 and AQP9 expression. Acta Pharmacologica Sinica. 2015.
Yu, L.; Fan, Y.; Ye, G.; Li, J.; Feng, X.; Lin, K.; Dong, M.; Wang, Z. Curcumin alleviates brain edema by lowering AQP4 expression levels in a rat model of hypoxia-hypercapnia-induced brain damage. Experimental and Therapeutic Medicine, 11, 709 - 716. 2016.
Kahle, K.T.; Simard, J.M.; Staley, K.J.; Nahed, B.V.; Jones, P.S.; Sun, D. Molecular Mechanisms of Ischemic Cerebral Edema: Role of Electroneutral Ion Transport. Physiology, 24(4), 257. https://doi.org/10.1152/physiol.00015.2009. 2009.
Kwong, K.C.N.K.; Mehta, A.R.; Nedergaard, M.; Chandran, S. Defining novel functions for cerebrospinal fluid in ALS pathophysiology. Acta Neuropathologic Communications, 8(1). https://doi.org/10.1186/s40478-020-01018-0. 2020.
Medeiros, R.; Kitazawa, M.; Passos, G.F.; Baglietto ‐Vargas, D.; Cheng, D.; Cribbs, D.H.; LaFerla, F.M. Aspirin-Triggered Lipoxin A4 Stimulates Alternative Activation of Microglia and Reduces Alzheimer Disease–Like Pathology in Mice. American Journal of Pathology, 182(5), 1780. https://doi.org/10.1016/j.ajpath.2013.01.051. 2013.
Guadagna, S.; Barattini, D.F.; Roşu, Ş.; Ferini‐Strambi, L. Plant Extracts for Sleep Disturbances: A Systematic Review. Evidence-Based Complementary and Alternative Medicine, 2020(1). https://doi.org/10.1155/2020/3792390. 2020.
Kazemi, A.; Shojaei‐Zarghani, S.; Eskandarzadeh, P.; Hashempur, M.H. Effects of chamomile (Matricaria chamomilla L.) on sleep: A systematic review and meta-analysis of clinical trials. Complementary Therapies in Medicine, 84, 103071. https://doi.org/10.1016/j.ctim.2024.103071. 2024.
Lairikyengbam, D.; Wetterauer, B.; Schmiech, M.; Jahraus, B.; Kirchgessner, H.; Wetterauer, P.; Berschneider, K.M.; Beier, V.; Niesler, B.; Balta, E.; Samstag, Y. Comparative analysis of whole plant, flower and root extracts of Chamomilla recutita L. and characteristic pure compounds reveals differential anti-inflammatory effects on human T cells. Frontiers in Immunology, 15. 2024.
De Cicco, P.; Ercolano, G.; Sirignano, C.; Rubino, V.; Rigano, D.; Ianaro, A.; Formisano, C. Chamomile essential oils exert anti-inflammatory effects involving human and murine macrophages: Evidence to support a therapeutic action. Journal of ethnopharmacology, 116391. 2023.
Nargesi, S.; Moayeri, A.; Ghorbani, A.; Seifinejad, Y.; Shirzadpour, E. The effects of Matricaria chamomilla L. hydroalcoholic extract on atherosclerotic plaques, antioxidant activity, lipid profile and inflammatory indicators in rats. Biomedical Research and Therapy. 2018.
Rodríguez-Cruz, A.; Romo-Mancillas, A.; Mendiola-Precoma, J.; Escobar-Cabrera, J.; García-Alcocer, G.; Berumen, L.C. "Effect of valerenic acid on neuroinflammation in an MPTP-induced mouse model of Parkinson's disease". IBRO Reports, 8, 28 - 35. 2019.
Al-kuraishy, H.M.; A.Al-windy, S.; Al-Gareeb, A.I. Beneficial Neuro-Pharmacological Effect of Passionflower (Passiflora Incarnate L). Online Journal of Neurology and Brain Disorders. 2020.
Ingale S.P.; Kasture S.B. Antioxidant and antiparkinsonian activity of Passiflora incarnata. Oriental Pharmacy and Experimental Medicine 14(3):231-236. 2014.
Ayaz, M.M.; Sadiq, A.; Junaid, M.; Ullah, F.; Subhan, F.; Ahmed, J. Neuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants. Frontiers in Aging Neuroscience, 9. 2017.
Morin, C.M.; Koetter, U.; Bastien, C.H.; Ware, J.C.; Wooten, V. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. Sleep, 28 11, 1465-71. 2005.
Müller, S.F.; Klement, S. A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine: international journal of phytotherapy and phytopharmacology, 13 6, 383-7. 2006.
Maroo, N.; Hazra, A.; Das, T. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: A randomized controlled trial. Indian Journal of Pharmacology, 45, 34 - 39. 2013.
Sutton, E.L. Psychiatric Disorders and Sleep Issues. Medical Clinics of North America, 98(5), 1123. https://doi.org/10.1016/j.mcna.2014.06.009. 2014.
Patel, A.K.; Reddy, V.D.K.; Araújo, J.F. Physiology, Sleep Stages. 2021.
Nollet, M.; Hicks, H.; McCarthy, A.; Wu, H.; Möller‐Levet, C.S.; Laing, E.; Malki, K.; Lawless, N.; Wafford, K.A.; Dijk, D.; Winsky‐Sommerer, R. REM sleep's unique associations with corticosterone regulation, apoptotic pathways, and behavior in chronic stress in mice. Proceedings of the National Academy of Sciences, 116(7), 2733. https://doi.org/10.1073/pnas.1816456116. 2019.
Krause, A.; Simon, E.B.; Mander, B.A.; Greer, S.M.; Saletin, J.; Goldstein‐Piekarski, A.; Walker, M.P. The sleep-deprived human brain. Nature Reviews. Neuroscience, 18(7), 404. https://doi.org/10.1038/nrn.2017.55. 2017.
Krystal, A.D. Psychiatric Disorders and Sleep. Neurologic Clinics, 30(4), 1389. https://doi.org/10.1016/j.ncl.2012.08.018. 2012.
Gallo, G.G.; Curado, D.F.; Machado, M.P.A.; Espíndola, M.I. de; Scattone, V.V.; Noto, A.R. A randomized controlled trial of mindfulness: effects on university students' mental health. International Journal of Mental Health Systems, 17(1). https://doi.org/10.1186/s13033-023-00604-8. 2023.
Martire, V.L.; Berteotti, C.; Zoccoli, G.; Bastianini, S. Improving Sleep to Improve Stress Resilience. Current Sleep Medicine Reports, 10(1), 23. https://doi.org/10.1007/s40675-024-00274-z. 2024.
Kim, J. P. W. J. Resilience through Sleep. Journal of Sleep Disorders & Therapy, 1(2). https://doi.org/10.4172/2167-0277.1000e105. 2012.
Anghel, L.; Ciubara, A.B.; Nechita, A.; Nechita, L.; Manole, C.; Baroiu, L.; Ciubară, A.B.; Musat, C.L. Sleep Disorders Associated with Neurodegenerative Diseases. Diagnostics, 13. 2023.
Auger, R.R.; Boeve, B.F. SLEEP AND NEURODEGENERATE DISORDERS. CONTINUUM: Lifelong Learning in Neurology, 13, 201-224. 2007.
Owen, J.E.; Veasey , S.C. Impact of sleep disturbances on neurodegeneration: Insight from studies in animal models. Neurobiology of disease, 104820. 2020.
Shen, Y.; Lv , Q.; Xie , W.; Gong, S.; Sheng, Z.; Liu, J.; Mao, C.J.; Liu, C.F. Circadian disruption and sleep disorders in neurodegeneration. Translational Neurodegeneration, 12. 2023.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
